1[1]Coutinho K,Gerstein HC,Wang Y,et al.The relationship between glucose and incident cardiovascular events:a metaregression analysis of published data of 20 studies of 95,783 individuals followed for 12.4 years[J].Diabetes Care 1999,22(2)∶233-40.
2[2]Standl E,Balletshofer B,Dahl B,et al.Predictors of 10-year macrovascular and overall mortality in patients with NIDDM:the munich general practioner project[J].Diabetologia 1996,39(12)∶1540-5.
3[3]UK Prospective Diabetes Study(UKPDS):The effect of inensiveblood-glucose control with meformin on complications in overweith patients with type 2 diabetes(UKPDS 34)[J].Lancet 1998,352(9131)∶854-65.
4[4]Malmberg K.Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus.DIGAMI(Diabetes Mellitus,Insulin Glucose Infusion in Acute Myocardial Infarction)Study Group[J].BMJ 1997,314(7093)∶1512-5.
5[5]Isomaa B,Almgren P,Tuomi T,et al.Cardiovascular morbidity and mortality associated with the metabolic syndrome[J].Diabetes Care 2001,24(4)∶863-9.
6[6]Minamikawa J,Tanaka S,Yamauchi M,et al.Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes[J].J Clin Endocrinol Metab 1998,83(5)∶1818-20.
7[7]Isles CG,Paterson JR.Identifying patients at risk for coronary heart disease:implications from trials of lipid-lowering drug therapy.QJM 2000,93(9)∶567-74.
8[8]Pyrorala K,Pedersen TR,Kjehshus J,et al.Cholesterol lowering with Simvastatin improves prognosis of diabetic patients with coronary heart disease:A subgroup analysis of the Scandinavian Simvastatin Survival Study(4S)[J].Diabetes Care 1997,20(4)∶614-20.
9[9]Goldberg RB,Mellies MJ,Sacks FM,et al.Cardiovascular events and their reduction with pravastatin in diabetic and glucose-tolerant myocardial infarction survivors with average cholesterol levels:subgroup analyses in the cholesterol and recurrent events (CARE) trial[J].The Care Investgations:Circulation 1998,98(23)∶2513-19.
10[10]Hansson L,Zanchetti A,Carruthers SG,et al.Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension:pricipal results of the Hypertensive Optimal Treatment(HOT)randomised trial[J].Lancet 1998,351(9118)∶1755-62.
